Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00692783 · ClinicalTrials.gov registry record
Incidence of Oral Candidiasis, Prevalence of C. Dubliniensis in HIV Patients and In-vitro Azole Susceptibility
A clinical trial, sponsored by University of Florida.
- Terminated
- Registry status
- 10
- Enrollment target
NCT00692783 is a clinical trial that was terminated before completion, run by University of Florida. The registered enrollment target is 10 participants.
The verdict
NCT00692783 was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
C. dubliniensis has been identified as pathogen in Oropharyngeal Candidiasis(OPC)particularly among HIV patients. Azole therapy is a cornerstone in OPC, but resistance within C. dubliniensis isolates to diflucan is common.This is a prospective collection of biological specimens from oropharyngeal cavity with the purpose of determining the prevalence of C. dubliniensis in HIV/AIDS patients at the Duval County Department of Health Comprehensive care Center. It is hereto proposed an estimation of azole-resistance in these isolates.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2008-05 |
| Est. Completion | 2009-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00692783
The ClinicalTrials.gov registry entry for NCT00692783 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00692783 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00692783 about?
NCT00692783 is a clinical study titled "Incidence of Oral Candidiasis, Prevalence of C. Dubliniensis in HIV Patients and In-vitro Azole Susceptibility". C. dubliniensis has been identified as pathogen in Oropharyngeal Candidiasis(OPC)particularly among HIV patients. Azole therapy is a cornerstone in OPC, but resistance within C. dubliniensis isolates to diflucan is common.This is a prospective collection of biological specimens from oropharyngeal ca...
What is the current status of trial NCT00692783?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2008-05. Estimated completion is 2009-01.
Who is sponsoring clinical trial NCT00692783?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.